User shared progress pictures after 3 months of using 1mg finasteride, 5% minoxidil, a dermaroller, and castor oil. They humorously commented on their results.
The user experienced significant hair regrowth over three months using 1.25mg oral finasteride, 5mg oral minoxidil, and weekly dermarolling. Initial side effects included mood swings, but these stabilized over time.
The user is using finasteride (1 mg daily), topical minoxidil, and microneedling with a derma stamp for hair loss. They reported shedding stopped and new hair growth appeared after a few months, with no side effects.
A user who was part of an ongoing trial for a prolactin blocker and had regrowth, but the progress photos were not shared due to negative reactions from other users. Treatments mentioned include HMI-115, Minoxidil, Finasteride, and RU58841.
The user completed their first month using oral finasteride and topical minoxidil without issues but is concerned about a 2-3 day gap in their finasteride supply affecting progress. They are also seeking advice on obtaining a multi-month supply.
A 21-year-old male shares progress on hair regrowth using dutasteride, minoxidil, and ketoconazole for one year, noting significant regrowth despite initial shedding. Users discuss their experiences with shedding and inquire about the form of minoxidil used.
A 21-year-old experienced hormone changes after using self-made topical finasteride for hair loss, including a 20% decrease in DHT, a 47% increase in testosterone, and a 39% increase in estradiol. The user previously used minoxidil and microneedling but is now seeking ways to balance hormones, possibly through supplements or dosage adjustments.
Hair loss treatments like spironolactone often require lifelong use to maintain results. Stopping the medication can lead to increased testosterone levels and potential hair loss.
The user is experiencing ongoing hair loss despite using a comprehensive treatment regimen including dutasteride, oral minoxidil, cyproterone acetate, transdermal estradiol, and topical bicalutamide. They suspect cyproterone acetate may be worsening their hair loss and are considering switching to injection monotherapy.
A 26-year-old male is using a combination of clomiphene, minoxidil, tadalafil, bupropion, and lisdexamfetamine to address low testosterone, ED, depression, and focus issues. He seeks input on the safety and efficacy of this regimen, which also includes magnesium, zinc, and fish oil supplements.
An 18-year-old woman experiencing hair loss due to stress, possible PCOS, and low vitamin D is concerned about starting 5% minoxidil foam, prescribed by her doctor, due to potential facial hair growth. She is also using a topical steroid for scalp sensitivity and pain.
A female, aged 17-18, is experiencing significant hair loss, feeling hopeless despite trying various treatments like leave-in conditioners, omega-3s, supplements, sulfate-free shampoo, and biotin. She is distressed as her hair continues to thin, affecting her body image and self-esteem.
The user is experiencing increased hair shedding after one year of using oral dutasteride. They are seeking opinions on their DHT test results, which show levels below baseline.
PP405 is progressing rapidly through trials, with mixed opinions on its potential effectiveness. Current treatments like minoxidil and finasteride are still widely discussed, with some users reporting positive results from new formulations.
A 22-year-old male's 14-month hair loss treatment journey, starting with daily doses of dutasteride and minoxidil, then reducing dutasteride frequency, and finally switching to finasteride while maintaining daily minoxidil. Despite reduced libido, he's satisfied with his hair progress, started seeing results after 2 months, and believes finasteride is effective for maintenance.
The user took dutasteride 0.5mg 3-4 times a week and 5mg oral minoxidil daily, with a 3-month break at the 4-month mark, and emphasized not stopping minoxidil for better progress. They experienced good hair regrowth with no side effects after reducing dutasteride frequency.
The user is pausing finasteride for blood donation and is concerned about its effect on DHT levels. They plan to supplement with saw palmetto and pumpkin seed oil during the pause.
PP405 shows promise for reactivating hair follicles, with potential maintenance using 5AR inhibitors. Current treatments like Minoxidil and finasteride are effective but have limitations, and there is hope for more effective solutions in the future.
A 29-year-old male with diffuse thinning plans to start minoxidil and finasteride soon but is concerned about potential shedding before a big event in late April/early May. He is considering whether to start treatment now or wait until after the event.
The user has been using finasteride for 4 months and minoxidil for over a year, experiencing significant hair loss and thinning. Others suggest it might be a shedding phase, with some users sharing similar experiences and eventual regrowth, while others express skepticism about the effectiveness of the treatments.
The user used Dutasteride 0.5mg and Minoxidil 2.5 daily from February to December 2023, resulting in thicker hair without much change to the hairline. Brand and shedding were discussed, but no specific brand was mentioned, and no answer was given about shedding.
Clascoterone is being discussed as a promising new hair loss treatment, showing significant improvement in trials. Despite this, skepticism persists about its effectiveness, cost, and side effects, with some users preferring minoxidil and finasteride.
The user reported significant hair regrowth and thickening after 5 months using finasteride, minoxidil 5%, biotin, and derma stamping. They experienced some fatigue but no sexual side effects and plan to continue the treatment.
A trans woman is using finasteride, minoxidil, microneedling, and HRT to address hair loss, with noticeable improvement in hairline shape and presence of vellus hairs. She is considering hair transplants if these treatments don't yield desired results within a year or two.
User restarted hair loss treatment with consistent finasteride, minoxidil, ketoconazole shampoo, and weekly dermarolling. Another user shared their regimen including dutasteride, oral minoxidil, RU58841, derma roller, ketoconazole shampoo, and stemoxydine.
The user has been using finasteride and dutasteride for hair loss but is experiencing low energy and motivation, possibly due to high prolactin levels. Despite treatment, hairline recession continues, and the user is considering the impact of low DHT levels on overall health and energy.
User is experiencing severe hair loss despite using finasteride for 15 months, losing 500 hairs a day and 50% density since June. Minoxidil with needling was ineffective, and RU58841 is too expensive and hard to obtain.
A user's progress with a hair loss treatment regimen consisting of minoxidil, finasteride, and dermarolling once a week over four months; other users have offered encouragement and advice.
Hair loss treatments discussed include Minoxidil, Finasteride, and RU58841. HMI-115, a monoclonal antibody drug, is in phase 1 and 2 trials for different conditions, but its availability on the gray market is unlikely due to high production costs.
The user completed 6 months of using topical liquid minoxidil and oral finasteride, experiencing initial hair shedding followed by gradual regrowth after 2 months. They also dealt with dandruff and reported no negative impact on sex drive.